100 related articles for article (PubMed ID: 22695101)
1. Squamous cell carcinoma of the skin induces considerable sustained cost of care in organ transplant recipients.
Rüegg CP; Graf N; Mühleisen B; Szucs TD; French LE; Surber C; Hofbauer GF
J Am Acad Dermatol; 2012 Dec; 67(6):1242-9. PubMed ID: 22695101
[TBL] [Abstract][Full Text] [Related]
2. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
3. Validity of patient skin cancer report among organ transplant recipients.
Dybbro E; Mihalis E; Hirose R; Arron ST
Clin Transplant; 2012; 26(2):E132-6. PubMed ID: 22428900
[TBL] [Abstract][Full Text] [Related]
4. Pronounced allelic imbalance at D9S162 in skin squamous cell carcinoma of organ transplant recipients.
Mühleisen B; Petrov I; Frigerio S; Dziunycz P; French LE; Hofbauer GF
Arch Dermatol; 2012 Jun; 148(6):697-703. PubMed ID: 22508773
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
6. Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience.
Buell JF; Hanaway MJ; Thomas M; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):962-3. PubMed ID: 15848591
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
8. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
Dziunycz P; Hofbauer GF
Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
[TBL] [Abstract][Full Text] [Related]
9. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma in organ transplant recipients: approach to management.
Carucci JA
Skin Therapy Lett; 2004 Apr; 9(4):5-7. PubMed ID: 15146264
[TBL] [Abstract][Full Text] [Related]
12. Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients.
Muehleisen B; Schaerer L; Dummer R; Burg G; Hofbauer GF
J Cutan Pathol; 2007 Jan; 34(1):1-6. PubMed ID: 17214847
[TBL] [Abstract][Full Text] [Related]
13. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients.
Lott DG; Manz R; Koch C; Lorenz RR
Transplantation; 2010 Sep; 90(6):683-7. PubMed ID: 20808266
[TBL] [Abstract][Full Text] [Related]
14. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.
Mühleisen B; Petrov I; Gächter T; Kurrer M; Schärer L; Dummer R; French LE; Hofbauer GF
Histopathology; 2009 Jul; 55(1):67-76. PubMed ID: 19614769
[TBL] [Abstract][Full Text] [Related]
15. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients.
Drake AL; Walling HW
J Am Acad Dermatol; 2008 Jul; 59(1):68-71. PubMed ID: 18440666
[TBL] [Abstract][Full Text] [Related]
16. [Clinico-histologic characteristics of spinocellular carcinoma of the skin].
Stojanović S; Poljacki M; Vucković N; Tasić S
Med Pregl; 1998; 51(1-2):61-7. PubMed ID: 9531777
[TBL] [Abstract][Full Text] [Related]
17. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992.
Gray DT; Suman VJ; Su WP; Clay RP; Harmsen WS; Roenigk RK
Arch Dermatol; 1997 Jun; 133(6):735-40. PubMed ID: 9197827
[TBL] [Abstract][Full Text] [Related]
18. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with large cutaneous squamous cell carcinomas.
Renzi C; Mastroeni S; Passarelli F; Mannooranparampil TJ; Caggiati A; Potenza C; Pasquini P
J Am Acad Dermatol; 2010 Sep; 63(3):404-11. PubMed ID: 20598396
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control study.
Joly P; Bastuji-Garin S; Frances C; Lebbe C; Aubin F; Penso-Assathiany D; D'incan M; Avril MF; Lair G; Barete S; Euvrard S
Transplantation; 2010 May; 89(10):1224-30. PubMed ID: 20559031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
